Skip to main content
. 2015 Sep 5;128(17):2346–2353. doi: 10.4103/0366-6999.163375

Figure 3.

Figure 3

Western blotting analysis of myocardium Wnt3a. The Wnt3a (37 kDa) (a), was analyzed by Western blot with specific Wnt3a antibody at the end of reperfusion. Three hearts were used in each group. Data are reported as means ± standard deviation. *P < 0.05 versus S; P < 0.05 versus ischemia-reperfusion; P < 0.05 versus sevoflurane preconditioning (one-way ANOVA); Western blot analysis of myocardium p-GSK3β. The p-GSK3β (47 kDa) (b) was analyzed by Western blot with specific p-GSK3β antibody at the end of reperfusion. Three hearts were used in each group. Data are reported as means ± standard deviation. *P < 0.05 versus S; P < 0.05 versus ischemia-reperfusion; P < 0.05 versus sevoflurane preconditioning (one-way ANOVA); Western blot analysis of myocardium β-catenin. The β-catenin (c) was analyzed by Western blot with specific β-catenin antibody at the end of reperfusion. Three hearts were used in each group. Data are reported as means ± standard deviation. *P < 0.05 versus S; P < 0.05 versus ischemia-reperfusion; P < 0.05 versus sevoflurane preconditioning (one-way ANOVA).